| 당뇨병 약제의 선택:제2형 당뇨병의 고혈당 치료에 대한 2009 년 ADA/EASD 합의안을 중심으로 |
|
고관표 |
|
제주대학교 의과대학 내과학 교실 |
| Selection of the optimal hypoglycemic agent for type 2 diabetes: based on the 2009 consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes |
|
Gwanpyo Koh |
|
Department of Internal Medicine, Jejuju National University College of Medicine, Jeju, Korea |
Correspondence:
Gwanpyo Koh, Email: okdom@medimail.co.kr
|
|
|
| Abstract |
|
The management of hyperglycemia, the hallmark metabolic abnormality associated with type 2 diabetes, has taken center stage in the treatment of diabetes. The development of new classes of blood glucose-lowering medications to supplement the older therapies has increased the number of treatment options available for type 2 diabetes. The increased number of choices available to practitioners and patients has heightened uncertainty regarding the most appropriate means of treating this widespread disease. The ADA/EASD consensus algorithm for the medical management of type 2 diabetes was published in January 2009. I introduced the consensus approach to the management of hyperglycemia to help guide health care providers in choosing the most appropriate interventions for their patients with type 2 diabetes. |
| Key Words:
Type 2 diabetes, Hypoglycemic agent, Treatment, Guideline |
PDF Links
Full text via DOI
Download Citation
